繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

AN2 Therapeutics Adopts Rights Plan After BML Investment Partners Nears 20% Stake

2024-08-16 20:35

08:35 AM EDT, 08/16/2024 (MT Newswires) -- AN2 Therapeutics (ANTX) said Friday it adopted a shareholder rights plan after investor BML Investment Partners acquired additional shares to increase its stake in the pharmaceutical firm to nearly 20% within a week.

BML has acquired a total of 19.3% of AN2's stock as of Wednesday, a jump from a 14.2% stake as of Monday, according to regulatory filings.

Under the rights plan, each common share held by stockholders of record on Aug. 29 will be granted one preferred stock purchase right to purchase one one-thousandth of a share of newly created series A junior participating preferred stock at an exercise price of $6.50.

The board of directors are entitled to redeem the rights at $0.01 per right at any time before any shareholder has acquired at least 20% of the outstanding common stock, the company said.

The rights will expire on Aug. 15, 2025.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。